The rapidly changing nature of novel psycho active substance use
Download
1 / 115

The rapidly changing nature of novel psycho-active substance use - PowerPoint PPT Presentation


  • 64 Views
  • Uploaded on

The rapidly changing nature of novel psycho-active substance use. Conference on Legal Highs & Clubbing Drugs: What’s the Story? Dr Russell Newcombe 3D Research, Liverpool Chelmsford, Essex, January 23 rd 2013. [email protected] www.3Dresearch.org.uk. The speaker.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' The rapidly changing nature of novel psycho-active substance use' - dixon


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
The rapidly changing nature of novel psycho active substance use

The rapidly changing nature of novel psycho-active substance use

Conference on Legal Highs & Clubbing Drugs: What’s the Story?

Dr Russell Newcombe

3D Research, Liverpool

Chelmsford, Essex, January 23rd 2013

[email protected]


The speaker
The speaker use

Dr Russell Newcombe, BA (Hons) & PhD in Social Psychology

Awards: National Rolleston Award for harm-reduction (HRI 2010);

Bing Spear Medal for drug policy reform (DPRG 2011);

Scientific Committee Award: drugs journal paper (EMCDDA 2011)

30 years as specialist researcher, trainer and lecturer in the field of psychoactive drug use, deviancy and disorder

Currently Director of 3D Research, an independent agency based in Liverpool, Merseyside, UK

Areas of expertise: prevalence, consumption and effects of drugs; harm-reduction services & strategies; evaluation;

‘legal highs’ (use of new/unregulated drugs)


Nps legal highs key questions
NPS use/Legal Highs: key questions

1. What are ‘legal highs’ and/or novel psychoactive drugs (NPS)?

2. What are the main types of NPS currently used, and what are

the main trends in the production and sale of NPS?

3. What is the current prevalence of NPS use in the UK?

4. Who are NPS used by, and why are they used?

5. What are the effects of NPS on the body and mind?

6. What are the main risks and potential harms of NPS? 

7. How should society respond to users of new psychoactive

drugs (policy and services)?


1 what are legal highs
1. What are ‘ uselegal highs’

  • Chemicals which alter the normal functioning of the brain – neurotransmitters and brain-waves - thus producing changes in our experience and behaviour [i.e. a ‘high’]

    (2) Specifically, a ‘legal high’ is a chemical which is:

    (a) not controlled by the 1971 Misuse of Drugs Act;

    (b) not licensed for legal use (like alcohol and tobacco);

    (c) not advertised/sold – and therefore not regulated - as

    a medicine (Medicines Act 1968) – see next 2 slides;

    AND: mimics the effects of popular controlled drugs [?]

    Thus, a legal high is a substance which is not legally regulated

    – a more accurate term would be ‘legal loophole’ drugs.


Novel psychoactive substances nps
Novel psychoactive substances (NPS) use

Over the last few years, the term ‘legal high’ has become replaced by ‘novel psychoactive substance’ (NPS) – because if and when possession and trafficking of a particular new drug is prohibited by the government, it ceases to be a ‘legal high’.

For example, use of the term ‘NPS’ allows us to avoid the confusion which currently exists in relation to drugs like mephedrone (meow/m-cat), which was banned by the UK government in April 2010, but is still referred to as a ‘legal high’ by some sources (notably the mass media).


What makes a drug a medicine
What makes a drug a medicine? use

The classification of drug products as medicines is made on a case-by-case basis by the Medicines and Healthcare products Regulatory Agency (MHRA) under the Medicines Act 1968 and the amended Medicines for Human Use Regulations 1994 (marketing authorisations etc.) .

Medicines are also classified into Schedules 1 to 5, which determine the control of prescribing and dispensing, eg. Schedule 1 drugs cannot be prescribed or dispensed (no medical use = totally prohibited, eg. most hallucinogens);

Schedule 5 drugs can be dispensed without prescription.


The legal loophole used by nps
The legal loophole used by NPS use

Headshops and online retailers of ‘legal highs’/NPS get round the UK Medicines Act legislation by stating that their products are not for human consumption, i.e. by definition not a medicine.

Instead product packaging typically contains a cross/bones (sign of toxicity), and a warning not to consume the substance – using euphemisms such as bath salts, pond cleaner, room odoriser, incense, cream dispenser refills – and the vaguer product descriptors ‘souvenirs’ and ‘research chemicals’.

Packaging also typically states ‘for sale to adults only’.


Legal highs forms sources
Legal Highs: forms & sources use

FORMS Liquid (solvents, solutions, sprays)

Gas (eg. nitrous oxide)

Solid (powder, pills, capsules, organics) *

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SOURCES Herbal (leaf, bud, root, seed, sap, etc.) *

Animal (excretions, organs)

Technological: Synthetic chemicals *

Electronic devices

(eg. brain tuners, binaurals)

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OUTLETS: (1) town/city headshops & (2) online websites

*Most common forms at 2012


Headshops famous uk chain
Headshops: famous UK chain use

Sell ‘legal highs’ and drug-related paraphernalia and literature

Dr Hermans at Bold Street in

Liverpool UK


Online sale of research chemicals
Online sale of research chemicals use

For example: BULK RESEARCH CHEMICALS

“We are the UK's favourite vendor of research chemicals and run constant quality checks across our whole spectrum of research chemical products. We sell the UK's most popular research chemicals at the best web prices such as Methoxetamine (MXE), MDAI and Methiopropamine (MPA).”

  • Combo 1 - MPA 1g & MDAI 1g

  • This pack contains 1g each of MDAI and MPA aka methiopropamine. £24.00

    www.bulkresearchchemicals.com


Online legal highs sites explode
Online useLegal Highs sites explode

Typing “buy legal highs” into Google throws up 2.74 million results, while “buy research chemicals” produces 6.91 million options [August 2012]

The Misuse of Drugs Act now covers over 600 substances, but it is 40 years out of date and struggles to keep pace with the sheer amount of new chemical compounds hitting the UK recreational drug scene each year

http://m.londonlovesbusiness.com/3267.article


2 main types of nps being sold from headshops websites to 2012
2. Main types of NPS being sold from headshops & websites to 2012

Main illegal drugs being mimicked

Phenethylamines ecstasy (MDMA), amphetamines

Tryptamines LSD, psilocin, DMT

Piperazerines ecstasy, amphetamines

Cathinones amphetamines, cocaine

Cannabinoids THC (cannabis), hallucinogens, sedatives

Miscellaneous stimulant/sedative/hallucinogen/opioid

Source: EMCDDA-Europol Annual Report on the implement-ation of Council Decision 2005/387/JHA [April 2012]


Timeline of legal highs novel drugs
Timeline of 2012legal highs (novel drugs)

Decade(s)Initially unregulated drugs becoming popular

1970s-80ssolvents (eg. butane, toluene); poppers (alkyl

nitrites); magic mushrooms (notably psilocybe)

Nineties ketamine; GHB (gammahydroxybutyrate)

(1991-2000)khat

Noughtiespiperazines (notably BZP); cathinones (notably

(2001-2010) mephedrone); GBL; N2O (laughing gas)

salvia divinorum; kratom

2011-2012 6APB (eg. Benzo Fury), MDAI (eg. Sparkle),

methoxetamine (eg. MXE); synthetic

cannabinoids (from JWH-018 to AM-2201)


17 new novel drugs 2011 12
17 new novel drugs, 2011-12 2012

The latest NPS found in Britain by FEWS (Forensic Early Warning System) between January 2011 and March 2012 – reads like a scrabble nightmare:

1. DMMA 9. 2-AI

2. MDAI (Sparkle) 10. n-ethylbuphedrone

3. Etizolam 11. 2-CC-NBoMe

4. JWH-250 12. AM-2201

5. JWH-200 13. Ipracetin

6. AM-694 14. Ethacetin

7. 4-Me0-PcP 15. 4-HO-MiPT

8. 5-Me0-DALT 16. 2-CP

17. 25D-NBOMe


Nps obtained from internet uk late 2011
NPS obtained from internet, UK, late 2011 2012

A total of 22 ‘legal high’ products were purchased from 5 different internet sites in late 2011 (18 months after the UK ban on substituted cathinones was introduced in April 2010), and each substance was screened to determine its active ingredients.

Two products – both labeled NRG2 – contained a banned drug: each had methylethcathinone (4-MEC), as well as a smaller amount of a 2nd banned cathinone: methylmethcathinone (mephedrone).

Six products (4 sold as Benzo Fury & 2 as NRG3) contained 6-APB; three contained MDAI; three contained 5-IAI; three contained methoxetamine; three contained benzocaine; & 2 contained MPA.

Source: Ayres T & Bond J (2012). A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs? BMJ Open, July 31, 2012; 2(4).


22 legal highs purchased on internet: compounds detected, accuracy of description & legal status (Ayres & Bond, 2012)


Review of nps websites 2012
Review of NPS websites 2012 accuracy of description & legal status (Ayres & Bond, 2012)

A survey of the internet was used to identify websites that were marketing legal highs in the UK. The most fruitful search terms included desoxypipradrol (Ivory Wave/2DPMP), diphenylprolinol (D2PM), methylenedioxy-2-amino-indane (MDAI), methylenedioxy-2-amino-tetralin (MDAT), alpha-methyltryptamine (AMT) & 5-methoxy-N,N-diallyl-tryptamine

Conclusions: “Legal highs from the phenylethylamine, cocaine, tryptamine and phencyclidine classes are increasingly being marketed,and, in the majority of cases, little is cited in the literature on their true chemical identity, pharmacology or toxicology”.

Source: Gibbons S (20120. 'Legal highs’ - novel and emerging psychoactive drugs: a chemical overview for the toxicologist.

Clinical Toxicology (Phila), January 2012; 50(1): 15-24


3 types of nps based on source
3 TYPES OF NPS BASED ON SOURCE accuracy of description & legal status (Ayres & Bond, 2012)

Herbal highs: plant/fungi or animal part/product

Synthetic highs: substance made by means of chemistry

- starting with natural precursors (semi-

synthetic) or synthetic chemicals

Mixed herbal/synthetic: products with synthetic drugs mixed into natural drugs, eg. Black Mamba: AM2201 chemical saturated into damiana leaves


Herbal highs

Chewed, smoked accuracy of description & legal status (Ayres & Bond, 2012)

or brewed/drank

Herbal Highs:

KHAT: herbal high (left) – but the most common headshop herbal high is salvia divinorum (below)

Contains cathinone - stimulant

hallucinogen


Kratom
Kratom accuracy of description & legal status (Ayres & Bond, 2012)

Kratom is a tropical tree indigenous to

South East Asia including Thailand, Malaysia,

& Myanmar. The Kratom tree can reach heights up to 50 feet with

a spread of over 15 feet. Normal ingestion methods include

drinking it as a tea, smoking it, and chewing the leaves.

It is sold from websites as dried leaves, powder and resin pellets.

It is stimulant in lower doses, and sedative (opiate-like) in higher

doses. Doses range from 2 to 10 grams.

Kratom has 25+ alkaloids, the primary psychoactive ingredient being mitragynine (9-methoxy-corynantheidine) Pharmacology studies show mitragynine has opioid-like activity in animals.


Synthetic cannabinoids history
Synthetic Cannabinoids: history accuracy of description & legal status (Ayres & Bond, 2012)

Synthetic cannabinoids are functionally related to THC - Δ9-tetrahydrocannabinol, the key active chemical in cannabis

Like THC, they bind to the same cannabinoid receptors in the brain and other organs as the endogenous ligand (brain neurotransmitter) anandamide.

Classed as cannabinoid receptor agonists, they were initially developed over past 40 years as therapeutic agents, often for the treatment of pain. However, it is difficult to separate the desired properties from unwanted effects (eg. getting stoned), and so pharma-companies did not market them.

But in 21st century, legal-high entrepreneurs began exploring, then marketing, these rejected therapeutic agents as legal cannabis substitutes.


Why the rise in interest in synthetic cannabinoid products
Why the rise in interest in synthetic cannabinoid products? accuracy of description & legal status (Ayres & Bond, 2012)

  • Part of general trend toward using legal highs

    (2) Cheaper & more reliable product - Police raids on skunk farms (E&W) – premises converted to cannabis cultivation, preventing ‘normal usage’:

    2006/7: 800 2009/10: 6,800

    2007/8: 3,000 2011/12: 7,900

    (3) Series of big rises in price of skunk since 2008 - average price of 1g skunk 2011 (Druglink survey): £10 – though since a gram-bag often weighs nearer 0.75g, the true gram price is probably nearer £13-14 – or £90 to £100 per quarter ounce

    (4) Skunk problems: dampness, mouldiness, adulteration


First group of synthetic cannabinoids banned in uk
First group of synthetic cannabinoids banned in UK accuracy of description & legal status (Ayres & Bond, 2012)

Spice, K2, Majik – mainly JWH series, but also CP & HU series


Black mamba am2201
Black Mamba (AM2201) accuracy of description & legal status (Ayres & Bond, 2012)

Legal-high smokables’ are often inert herbal mixtures with synthetic cannabinoids soaked into them (the latter are also sold separately as powders). For instance: Black Mamba (AM2201), Zulu, Doob


Herbal products containing synthetic cannabinoids accuracy of description & legal status (Ayres & Bond, 2012)

Black Mamba-type products are usually sold as herbal prep- arations containing inert herbal material (leaf etc.) saturated with synthetic cann- abinoids (SCs). The pure SC powder can also be got online.


Typical appearance of black mamba spice type products
Typical appearance of Black Mamba/Spice-type products accuracy of description & legal status (Ayres & Bond, 2012)

Unlike herbal cannabis, there are no seeds; unlike skunk, there are no buds; unlike either, there is no strong smell or sticky texture


Sale of black mamba in headshops
Sale of Black Mamba in headshops accuracy of description & legal status (Ayres & Bond, 2012)

Usually sold as ‘incense’ (herbal mixture) or ‘research chemicals’ (AM2201 powder), and labelled ‘not for human consumption’ & ‘not for sale to under-18s’

£10 for one-gram bag

£25 for three-gram bag

But just like illicit drugs, the actual weight is usually 5%-

20% less than described

------------------------------------------------------------------------

Black Mamba = three ‘drugs’ in one herbal mixture

> damiana

> AM2201 (fluoro-pentyl-naphthoyl-indole)

> oleamide


fluoropentyl-naphthoyl-indole accuracy of description & legal status (Ayres & Bond, 2012)

AM-2201synthetic cannabinoid: 1-gram

bag of off-white powder

Source: Bulk Research

Chemicals

www.bulkresearchchemicals.com

Light dose: 250 mcg

Moderate dose: 0.5 - 1 mg

Strong dose: 1 – 2 mg

NPS like ‘Black Mamba’ contain AM-2201 saturated into damiana leaf to simulate herbal cannabis in both its appearance and effects


Synthetic highs white powders pills
Synthetic highs: white powders & pills accuracy of description & legal status (Ayres & Bond, 2012)

BUBBLE

-------------------

UPPERS

or TRIPS


Conclusions of lancashire study
Conclusions of Lancashire study * accuracy of description & legal status (Ayres & Bond, 2012)

“whilst Bubble had been used as a slang term for mephedrone when it emerged in the north west of England in 2009, by late 2010 and after the ban, Bubble was evolving into the slang term for any synthetic legal high or unidentified white powder with stimulant effects which was available from street dealers …

our survey respondents were not only unclear about, but also apparently unconcerned about the specific chemical identity of the stimulant white powders they consumed” Measham et al. (2011: 140), op cit.

* [based on interviews with people attending nightclubs in North-West England, 2010]


Some lines of bubble earlier today
Some lines of Bubble earlier today accuracy of description & legal status (Ayres & Bond, 2012)

Cocaine – Heroin – Amphetamine – Ecstasy - 2CB – Ketamine – Mephedrone –Naphyrone - Methoxetamine? – or one of dozens of possible legal highs/NPS


1 benzofuran 6 ylpropan 2 amine 6 apb aka nrg3
1-Benzofuran-6-ylpropan-2-amine (6-APB) – accuracy of description & legal status (Ayres & Bond, 2012)aka ‘NRG3’

6APB – stimulant: note the use of the terms ‘research chemicals’ & ‘pellets’ (not pills), and the warnings ‘harmful’ and ‘not for human consumption’


Ivory wave desoxypipradol 2dpmp
Ivory Wave: accuracy of description & legal status (Ayres & Bond, 2012)desoxypipradol (2DPMP)


Ivory wave whack
Ivory Wave & Whack accuracy of description & legal status (Ayres & Bond, 2012)

Wood & Dargan used PubMed to search for terms related to D2PM & 2-DPMP (desoxypipradol). 2-DPMP, usually sold as ‘Ivory Wave’, was found to have similar effects on reducing dopamine reuptake to cocaine. D2PM was similar, but was far less biologically effective at boosting dopamine levels.

'Whack‘ was found on analysis to contain 2-DPMP and fluorotropacocaine, so also had similar effects to cocaine.

Wood D, Dargan P (2012). Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clinical Toxicology (Phila), September 2012; 50(8): 727-32.


Ethylphenidate
Ethylphenidate accuracy of description & legal status (Ayres & Bond, 2012)

Analogue of stimulant drug methylphenidate – better known as Ritalin (for ADHD)


Annihilation herbal incense
Annihilation: ‘herbal incense’ accuracy of description & legal status (Ayres & Bond, 2012)

Synthetic cannabinoid in herbal material, possibly AM2201 or one of its chemical relatives.

Given a great deal of free publicity by the mass media.


Legal high
Legal high? accuracy of description & legal status (Ayres & Bond, 2012)

50 mg tablets of caffeine (trimethylxanthine) – sold in pharmacies off the shelf to anyone aged 12 years or older.

“A stimulant which can help to maintain mental alertness and make you feel less tired”.

Max dose in 24 hours:

12 tablets (0.6 gram).

LD50 = 10 grams (or 4

packs of 48 tablets)

Online price 2012: £4.30


Electronic technological highs
Electronic/Technological Highs accuracy of description & legal status (Ayres & Bond, 2012)

Brain Tuners: computer programs that, via electrodes attached to skull, produce direct changes in brain-waves

- and thus stimulation, sedation or hallucinations

Perception Tuners: notably visual, tactile & sound-based (eg. hypnotic images, electro-acupuncture, binaurals)

The Chemputer (Cronin): makes molecules from atoms – and psychoactive drugs are typically comprised of two or more of just four atoms: carbon, hydrogen, oxygen and nitrogen

http://www.guardian.co.uk/science/2012/jul/21/chemputer-that-prints-out-drugs


Trends in nps availability
Trends in NPS availability accuracy of description & legal status (Ayres & Bond, 2012)

According to EMCDDA reports in May 2011 and November 2012, the number of new NPS marketed in Europe between 2008 & 2012 climbed as follows:

  • 13

  • 24

  • 41

    2011 49

    2012 57+ –the equivalent of more than one

    new NPS every week


Unodc report november 2012
UNODC report, November 2012 accuracy of description & legal status (Ayres & Bond, 2012)

Two drug groups - synthetic cannabinoids & cathinones - dominated the world NPS market over 2010 & 2011

Source: ‘Tracking designer drugs, legal highs and bath salts’ – UNODC 1-11-12

http://www.unodc.org/unodc/en/frontpage/2012/November/tracking-designer-drugs-legal-highs-and-bath-salts.html


Emcdda europol report 2012
EMCDDA/Europol Report 2012 accuracy of description & legal status (Ayres & Bond, 2012)

The number of NPS websites (online headshops) quadrupled in a two year period between January 2010 and January 2012:

Jan 2010 170

Jan 2011 314

July 2011 630

Jan 2012 690

In 2010/11, SOCA closed 120 websites for selling 2 newly controlled class B drugs: mephedrone (banned 4/10) and naphyrone (banned 7/10)


3 estimating levels of nps use
3. Estimating levels of NPS use accuracy of description & legal status (Ayres & Bond, 2012)

Problems with estimates of prevalence of NPS use

Parameters: time-period, place, case, type of estimate

Internal validity, eg. dummy drug items (false admissions), honesty questions (false denials)

Specific problem with NPS: large number & multiple names

External validity, eg. body fluid tests on a sub-sample

Reliability, eg. repeat questions, replicable surveys

Representativeness, eg. using sampling & statistical methods which ensure sample is representative of source population, so that findings are generalizable


Eu survey of legal highs mid 2011
EU Survey of legal highs, mid-2011 accuracy of description & legal status (Ayres & Bond, 2012)

EU survey in June 2011 found that of the 27 EU countries:

  • The UK was ranked fourth for legal high use (Ireland was first)

  • The UK ranked top for the proportion of legal high users who were offered them in clubs & parties


Prevalence of use of legal highs
Prevalence of use of accuracy of description & legal status (Ayres & Bond, 2012)legal highs

Mixmag survey: comparison of 2009 and 2010 findings *

% LifetimeLast-year

200920102010

poppers 69 56 20

nitrous oxide 59 57 38 (4 in 10)

mephedrone 42 61 51 (5 in 10)

salvia 29 .. ..

BZP 26 17 5

Spice/Magic 13 10 2

methylone 11 14 9

GBL 6 6 2

_________________________________________________________________________________________________

* 2009 findings reported in February 2010; 2010 findings given in March 2011

2010 sample: 69% male, modal age 20 years (3/4s 18-27), 89% heterosexual


British crime survey 2009 10 2011 12
British Crime Survey: 2009/10 - 2011/12 accuracy of description & legal status (Ayres & Bond, 2012)

Adults in England & Wales reporting last-year use of 5 drugs:

^ 367,000~ 220,000

16-59 16-24 .

09/1010/1111/1209/1010/1111/12

Mephedrone .. 1.4 1.1^ .. 4.43.3 ~

Spice * 0.4 0.2 0.1 1.2 0.4 ..

BZP 0.5 0.1 0.1 1.4 0.2 ..

Khat 0.2 0.2 0.2 0.5 0.3 ..

GBL/GHB 0.1 0.0 0.1 0.5 0.1 ..

_____________________________________________________________________

All five drugs were ‘legal highs’ until controlled by the UK Misuse of Drugs Act in 2010 – the exceptions being GHB (banned in 2005) & khat (still uncontrolled)

* and other synthetic cannabinoids .. not reported E&W = England & Wales

~ 95% CI: 173,000-267,000 last-year mephedrone users in E&W: 16-24s, 2011/12 (7th)

^ 95% CI: 317,000-416,000 last-year mephedrone users in E&W: 16-59s, 2011/12 (4th)


Global drug survey use of nps uk 2010 11
Global Drug Survey: use of NPS UK 2010/11 accuracy of description & legal status (Ayres & Bond, 2012)

% Last 12 months Last month

Nitrous oxide 27.2 ..

Mephedrone 19.5 7.2

Isopropyl nitrate (poppers) 13.1 5.2

Methoxetamine 4.2 2.4

Synthetic cannabis (some legal) 3.3 1.5

Benzo Fury (6APB) 2.4 0.8

MDAI (Sparkle) 2.2 0.5

Methylone 1.4 0.4

GBL (gammabutyrolactone) 1.6 0.5

MDPV (methylenedioxypyrovalerone) 0.5 0.0

AMT (alphamethyltryptamine) 0.4 0.2

Kratom 1.1 0.2

Solvents 0.4 0.2


4 who uses nps why
4. Who uses NPS, & why? accuracy of description & legal status (Ayres & Bond, 2012)

3 main groups:

Clubbers/partiers (mainly young adults & students)

Psychonauts (all ages - main interest is hallucinogens)

Poly-drug users (esp. prior cocaine/speed/heroin-users)

Demographics

About 2:1 male-female ratio for regular users

Main age-range of 16-45 – peak age-range 20-29 yrs

Gay men use (& initiate use) more than heterosexuals

Use found among all races & social groups, esp. Whites/Mixed


Characteristics of mephedrone users
Characteristics of mephedrone users accuracy of description & legal status (Ayres & Bond, 2012)

British Crime Survey 2011/12: levels of last-year use in E&W

Age: 16-19 (2.9%) & 20-24 (3.6%) vs 25-59 (0.5%)

Sex: men 1.5% vs women 0.7%

Ethnic group: white (1.2%) & mixed (1.9%) vs other races (0.3%)

Marital status: single (2.7%) vs others (0 to 1%)

Occupational status: students (2.7%) & unemployed (2.2%) vs others (0-1.3%)

Area: city-dweller (2.8%) vs others (0.5%-1.4%)

Past-month nightclub attendance: 9+ (9.7%) vs none (0.5%)

Past-month pub/bar attendance: 9+ (4.7%) vs none (0.3%)


Main reasons for taking legal highs
Main reasons for taking accuracy of description & legal status (Ayres & Bond, 2012)legal highs

Mixmag survey of readers/clubbers, 2009 (N = 2,220)

1 other illegal drugs not available

2 they are not illegal

2 able to buy them online

2 more reliable product than illegal drugs

2 price - cheaper than illegal drugs

6 better quality than illegal drugs

7 safer than illegal drugs

7 a better high & fewer side-effects than illegal drugs


Why have legal highs nps become so popular over the last 5 years
Why have accuracy of description & legal status (Ayres & Bond, 2012)legal highs/NPSbecome so popular over the last 5 years?

Not just because of price – many illegal drugs are cheaper than they were 20 years ago, and NPS can cost more.

Main reasons seem to be:

(1) the drop in the purity of several popular drugs (next slide)

(2) the drop in availability of some popular drugs (eg. skunk)

(3) the advent of the Internet and headshops as new ways of buying psychoactive drugs

(4) Entrepreneurs prepared to research, produce and market many new legal substances for getting ‘high’ (notably China)

(5) Modern society: consumer-oriented, pleasure-oriented


Sources of legal highs in uk
Sources of legal highs in UK accuracy of description & legal status (Ayres & Bond, 2012)

Mixmag survey of readers/clubbers, 2009 (N = 2,220)

%

Friends 95 nearly all

Websites 92 9 in 10

Headshops 78 8 in 10

Festival stalls 67 7 in 10

Drug dealers 51 half


5 the effects of nps
5. The effects of NPS accuracy of description & legal status (Ayres & Bond, 2012)

Categories of effects of drugs

Stages: Short-term: onset > main > residual Medium-term: after-effects, eg.come-down

Long-term: health/social, eg. dependence

--------------------------------------------------------------------------

Mental: thought emotion perception motivation

Physical: muscular respiratory circulatory sensory

digestive hormonal sexual facial


Snorting smoking fastest hits
Snorting & Smoking: fastest hits accuracy of description & legal status (Ayres & Bond, 2012)

…excluding injecting Swallowing delays effects by 30 to 90 minutes


  • The facial effects of stimulant / empathogen drugs accuracy of description & legal status (Ayres & Bond, 2012):

  • * bin-lids - dilated pupils of eyes

  • * wide-open eyelids, jerky eyes

  • * Flushed/hot-looking skin

  • * Clenched jaw, teeth-grinding

  • * Muscle-rippling, lip-chewing


The facial effects of depressant drugs (esp. opiate-type) accuracy of description & legal status (Ayres & Bond, 2012):

* pinned (constricted) pupils

* sagging/droopy eyelids

* paler complexion

* relaxed facial muscles

* nodding head (gouching)


Psychoactive drugs 2 dimensional model of their general effects
Psychoactive drugs: 2-dimensional model of their general effects

Hallucinogen

(trip)

|

Stimulant ▬▬ ▬▬ Depressant

(upper) | (downer)

Anti-psychotic

(normalizer)


Drugs classified by effects model
Drugs classified by effects model effects

Hallucinogen (trip)

LSD

MDMA| ketamine

|

Stimulant amphet. ▬▬ ▬▬ heroin Depressant (upper) | (downer)

nicotine | cannabidiol (CBD)

quetiapine (Seroquel)

Anti-psychotic (normalizer)

mephedrone

methoxetamine



Mephedrone hallucinations
Mephedrone Hallucinations effects

“I was staring at the pattern on the carpet in the centre of the room, and first some black smoke came up out of it, then I saw Michael Jackson float out of the smoke.

I said ‘that can’t be Michael Jackson, he’s dead’, and anyway I don’t even like Michael Jackson – then I thought ‘it’s OK, I’m in District-9’ – then I came right out of it, and felt shocked, real terrified ... I hope I see Elvis next time”.

R. Newcombe (2009). Mephedrone: the use of m-cat (Meow) in Middlesbrough. Manchester: Lifeline Publications.

http://www.lifeline.org.uk/wp-content/_old-site-docs/M-cat%20report%20small.pdf


6 risks harms from use of nps
6. Risks & Harms from use of NPS effects

RISKS HARMS .

Behaviours involved in Consequences of using

consumption of drugs drugs in specific ways

7 types of risk/safety9 types of harm/benefit

eg. Injecting with used needles Infections (eg. HIV, HCV)

Taking too-high doses Overdose

Toxicity of substance Bodily damage etc.


Risks of using nps legal highs
Risks of using NPS/ effectslegal highs

The Risk CAMP-MAP identifies the 7 core areas of the riskiness/ safety of drug consumption (drug-taking behaviour):

1 What drugs are they taking (at same time)? Mixture

2 How are they getting hold of it (who/where)? Access

3 What are the contents of products being used? Product

4 What setting do they use it in (place, time)? Context

5 How much are they using (per dose, per period)? Amount

6 How are they consuming it (prep. & admin.)? Method

7 How frequently & regularly are they using it? Pattern

Source: Newcombe R (2010). A multi-disciplinary theory of drug-related harm reduction. http://www.3dresearch.org.uk/?p=info


Model of drug related harms
Model of drug-related harms effects

L e v e l T y p e o f H a r m .

o f H a r mHealthSocialEconomic

Individual

Community

Societal


Main harms of nps legal highs
Main harms of NPS/ effectslegal highs

Health Problems

Mental disorder: anxiety, psychosis, mood

Dependence: craving, tolerance, withdrawals

Physical health: ‘route’ damage, diseases

Poisoning: acute intoxication, overdose

Death: fatal ODs, accidents, suicide

Social Problems: crime & CJS, relationships,

children, social exclusion, discrimination etc.

Economic Problems: personal debts, policy costs etc.

Extent of these problems: mostly unknown


Economic costs of drug prohibition
Economic costs of drug prohibition effects

THE UK spends more than any other country in Europe on its drugs policy – 0.48 per cent of GDP according to EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) – City AM 15/1/13


Image of left upper limb of patient 3 mephedrone injector post debridement
Image of left upper limb of Patient 3 (mephedrone injector) post debridement.

BODILY DAMAGE CAUSED BY MEPHEDRONE INJECTING

Causes: toxicity? adulterants? dose? injecting frequency?

Dorairaj J, Healy C, McMenamin M, Eadie P (2012). Journal of Plastic, Reconstructive & Aesthetic Surgery, 65, 37-41.


DEATHS post debridement.

The Sun Newspaper,

Thursday 3rd May 2012: article about death from use of “legal highs”, when the drug involved was GBL – which was banned in UK in December 2009


Trends in deaths from legal highs
Trends in deaths from ‘legal highs’ post debridement.

MephedroneBZP/TFMPPGBH/GBL

2001 0 0 1

2002 0 0 5

2003 0 0 6

2004 0 0 1

2005 0 0 4

2006 0 0 7

2007 0 0 9

2008 0 0 20

2009 0 9 16

2010 6 5 12

2011 6 2 20

Source: Office of National Statistics (England & Wales); 2012


Deaths related to legal inhalants
Deaths related to legal inhalants post debridement.

nitrous oxidepopperssolventshelium

2006 4 3 37 2

2007 3 2 39 2

2008 2 3 46 12

  • .. .. 31 21

  • .. .. .. 33

  • .. .. .. 40

    Sources: Office for National Statistics. Deaths related to drug poisoning in England & Wales 2010 (August 2011) .. Not available

    Trends in Death Associated With Abuse of Volatile Substances 1971-2009. St. Georges Hospital, University of London (2010).

    Note: helium deaths are mainly suicides Poppers = alkyl nitrites

    Inhalant: drug ingested by inhaling a gas or the fumes of room-temp. solvent


7 uk responses to use of nps
7. UK Responses to use of NPS post debridement.

Legal bans & controls

Police & CJS responses

Educational responses (schools, mass media

Hospital responses (A&E, psychiatric, etc.)

Treatment responses

Harm Reduction

Legal Regulation & Users’ Rights


Moda amendments tcdos 2011
MODA amendments: TCDOs 2011 post debridement.

  • Temporary Class Drug Orders - Police Reform &

    (Nov) Social Responsibility Act 2011, Sec. 151 & Sch. 17

    Home Office can place a drug in a TC if the ACMD

    advise that (a) it is or is likely to be misused, and

    (b) it has or could have harmful effects – and

    that a fast response is required to protect public.

    Covers all MoDA offences for 12 months – except

    possession, though police can still confiscate TCDs. Penalties as for class B/C (max. 14 years custody)

    In first 6 months, just one new drug has been placed under a TCDO: methoxetamine (MXE)


Import bans 2010 to 2012
Import bans, 2010 to 2012 post debridement.

2010 Import ban on desoxypipradol (2DPMP) [stimulant]

(Nov) {Ivory Wave}

2011 Import ban on phenazepam [benzo]

(June)

  • Import bans on pipradol analogues of 2DPMP)

    (Nov)

    2012 First TCDO under MoDA: methoxetamine

    (April) Also: 2DPMP (Ivory Wave) & phenazepam (Bonsai)

    [draft Misuse of Drugs Act 1971 (Amendment) Order 2012]


Banning of synthetic cannabinoids
Banning of synthetic cannabinoids post debridement.

Under the 2009 Amendment Order to MoDA 1971, four types of synthetic cannabinoid were added to class B, schedule 1 of Misuse of Drugs Act [see Appendix]

Further Consideration of Synthetic Cannabinoids (Oct 2012)

“The ACMD recommend that the substances detailed in Annex A have potential harms commensurate with those of cannabis and should, therefore, be classified and controlled under the Misuse of Drugs Act (1971) as Class B [and Schedule 1] under an extended generic definition”.

BUT many groups of synthetic cannabinoids remain legal…


Banning of arylcyclohexylamines
Banning of arylcyclohexylamines post debridement.

“the harms of methoxetamine are commensurate with Class B, of the Misuse of Drugs Act (1971); and it should be scheduled under Schedule I of the Misuse of Drugs Regulations (2001) (having no known recognised medicinal use). The ACMD also recommend that a number of closely related analogues of ketamine and phencyclidine, some of which have already appeared on sale as “legal high alternatives”, be controlled by means of a generic chemical description detailed in Annex 3.”

Advisory Council on the Misuse of Drugs, Methoxetamine Report, October 2012

But many groups of arylcyclohexylamines remain legal…


Prohibition of khat
Prohibition of khat? post debridement.

In January 2013, the UK government will make a decision about whether or not to control khat under the 1971 Misuse of Drugs Act


Acpo position on tcdos
ACPO position on TCDOs post debridement.

Submission from Association of Chief Police Officers to Home Affairs Select Committee on drugs policy, 2nd April 2012

“the solution to the particular challenge of legal highs does not lie in adding inexorably to the list of illicit substances.

A key question for the Government to determine is the extent to which legislation can realistically be used to address active choices being made by people and to tackle the undoubted harms caused by the misuse of substances taken essentially for pleasure.

The police will continue to focus their energies on serious criminality and take a less robust enforcement approach on matters relating to personal possession”

ACPO also warned the Government that the banning of ‘legal high’ drugs will fail, and forces will treat anyone found with them leniently –  cautioning instead of prosecuting them.


Other recent major reports re nps
Other recent major reports re NPS post debridement.

UK Drug Policy Commission: A Fresh Approach to Drugs (10/2012)

Recommended depenalization and harm reduction approach

Advisory Council on the Misuse of Drugs (October 2012)

Recommended decriminalizing the possession of drugs

Home Affairs Committee, House of Commons (December 2012)

9th Report: Drugs – Breaking the Cycle

Recommended decriminalization & harm reduction approach


All party parliamentary group for drug policy reform jan 2013
All-Party Parliamentary Group for Drug Policy Reform, Jan 2013

Towards a Safer Drug Policy: Challenges & Opportunities arising from ‘legal highs’ – Inquiry into New Psychoactive Substances

Recommended decriminalization and harm reduction policy

Proposed that the “less harmful” NPS be regulated and sold from retail pharmacies

UK PM David Cameron: rejected all of the recent calls for drug policy reform – including a Royal Commission on drug policy - yet in 2002 stated that the War on Drugs “does not work”


Attitudes of politicians top officials
Attitudes of politicians & top officials 2013

Government’s leading adviser, Prof Les Iversen (head of ACMD) said in October 2012 that young people caught in possession of banned substances such as cannabis should be spared criminal prosecution to prevent their futures being blighted

Ken Clarke, Justice Minister, also claimed in 2012 there was no evidence that the ‘war on drugs’ had had any effect over the past 30 years

Tom Hollis, drugs spokesman for the Association of Chief Police Officers stated in January 2013 that responsibility for drug policy should be moved from the Home Office to Dept of Health: “the police are ‘flat-footed’ trying to keep up with the pace of change” (eg. training sniffer dogs, etc.)


How many new drugs nps legal highs are possible
How many new drugs ( 2013NPS/legal highs) are possible?

“Each new substance that emerges from the laboratory is a tabula rasa: its effects on human consciousness cannot be predicted simply from its chemical structure … The permutations may be, to all practical purposes, infinite” (p105-6).

_____________________________________________

Mike Jay (2010). High Society: Mind Altering Drugs in History and Culture. London: Thames & Hudson


Legal regulation of psychoactive drugs
Legal regulation of psychoactive drugs 2013

Ultimately, legal regulation – as with alcohol and tobacco - may be the only viable solution to the exponential increase in ways of getting high which have emerged in the 21st century – from tweakable legal highs to electronic highs. If banning an NPS only leads to increased use and/or problems, the outcome is harm maximization not harm minimization.

The optimal solution would be to make available for adults’ private use the least toxic versions of each of the main kinds of psychoactive drug: notably stimulant, depressant, hallucinogenic and anti-psychotic drugs.

Transform’s report shows how legal regulation would work:

‘After the War on Drugs: Blueprint for Regulation’ (2009)


Responses to nps legal high use
Responses to NPS/legal high use 2013

Early-warning monitoring systems (eg. Drugwatch)

Multi-agency approaches – local & national

In-service staff training – to stay up to date – especially drugs workers & paramedics

Consultation with/representation of LH users

Exploration of prescribing/treatment options

Risk-reduction information – esp. online & apps

Working with headshops & ‘legal high’ websites

Research – evidence-based services/strategies


Monitoring systems
Monitoring systems 2013

European Monitoring Centre on Drugs & Drug Addiction:

EMCDDA Early Warning System - for new synthetic drugs

European Medicines Agency

Pharmacovigilance System - to monitor abuse of medicines

UK National Poisons Information Service – annual reports

FEWS – UK Home Office Forensic Early Warning System

Drugwatch


Substitute prescribing
Substitute prescribing 2013

Stimulant substitutes for mephedroneclass/schedule

dexamfetamine (Dexedrine): max dose 60 mg/day B2

methylphenidate (Ritalin, etc.)B2 .

modafinil (Provigil): average 100-200 mg per day POM

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Forms: tablets or syrup.

Medication for stabilizing & treating mephedrone users

anti-depressants (for mood disorders)

hypnosedatives (for sleep disturbances & anxiety)

vitamins/nutrients (for malnourishment)

______________________________________________________________________

POM = prescription only medicine (Medicines Act 1968)



Guide to safer use of hallucinogenic drugs 2013

(Lifeline Publications, Manchester 2005)

www.lifelinepublications.org

Apps for smartphones etc. are now one of the best mass media for providing information about safer use of legal and illegal drugs


Agency Interventions with NPS users 2013: needs

consultation with and representation of clients/users on policy-making groups and service providers



ABSTRACT: 2013The rapidly changing nature of novel psychoactive substance use

Issue. Although use of many illegal drugs has stabilized or declined over the 21st century, this has been accompanied by a significant rise in the use of 'legal highs' - unregulated novel psychoactive substances (NPS) designed to mimic the effects of banned drugs like cocaine, amphetamines, MDMA, cannabis and ketamine. Also, some NPS have fairly unique effects, and these include laughing gas (nitrous oxide), salvia and kratom. These NPS are sold online and from street headshops as 'not for human consumption' in order to sidestep medicine laws. First, ketamine, GBH and magic mushrooms became popular from the 1990s, followed by party pills (notably BZP), GBL and laughing gas during the early 'noughties'. But, following the government’s banning of most of these NPS, by 2008 the market for new synthetic drugs was showing a notable surge. In particular, sensationalist media coverage helped to make mephedrone (meow/m-cat/drone) and other cathinones (eg. methylone/bk-MDMA) the most popular NPS ever. Indeed, by 2010, the British Crime Survey reported that mephedrone had become the 4th most popular drug, resulting in the government banning it along with a dozen other cathinones. Predictably, by 2009, online and urban headshops responded to the cathinone ban by marketing a wide range of new NPS with a much wider variety of chemical structures, including Benzo Fury, Ivory Wave, Annihilation, Black Mamba and methoxetamine.

Key arguments. Indeed, according to a 2011 EMCDDA report, the number of NPS marketed in Europe climbed from 13 in 2008, to 24 in 2009, 41 in 2010, 49 in 2011, and over 57 in 2012 – the equivalent of more than one new NPS every week. The most popular new types of synthetic NPS include cannabinoids (eg. AM2201) and cathinones (eg. MDPV, NRG1), while the most popular natural NPS include salvia, khat and kratom. A further concern for the drugs field is the advent of electronic highs, which work through the brain’s perceptual and electrical systems rather than directly on its neurotransmitters - such as binaurals (mind-altering sounds), dream machines (mind-altering visual displays), and brain tuners (brain-wave modifiers).

Despite the vast numbers of NPS available, in October 2012 the UK government announced it would be banning just two main groups: synthetic cannabinoids such as Black Mamba and methoxetamine-type drugs (which had already been made the sole target of the new TCDO ‘holding class’). This clearly shows that the legal machinery available for controlling drugs is hopelessly out of date, and just as it failed to prevent the use of traditional drugs like cannabis and cocaine, UK drug laws are now patently failing to control use of NPS. Attempts at legal prohibition have been an outright failure - as demonstrated by the increase in mephedrone use and harm after it was banned - and interest in NPS continues to rise across many groups. For instance, an EC survey published in mid-2011 reported that one in 20 young adults (15-24s) across the EU's 27 countries had tried NPS - with the top four countries including Britain (one in 12) and Ireland (one in six).

Conclusion. This paper concludes by arguing that current British policies toward NPS are ineffective and counterproductive, and that interventions are urgently needed to minimize harm from NPS use – including advice and education on safer use, outreach work in clubs, relevant treatment responses (eg. substitute drug prescribing), and legal regulation which prioritizes harm reduction and respect for human rights over the criminalization of people who take drugs (a victimless crime).



Natural product legal highs
Natural product ‘legal highs’ 2013

“Natural product legal highs are by their very nature highly chemically complex, and in the clear majority of cases, chemical studies were conducted some considerable time ago. Their pharmacology and toxicology generally focuses on the major active principles with few studies detailing the potentially highly complicated and multiple effects of their extracts. This complexity, coupled with the inherent natural product variability of plant and fungal species, adds a further dimension to the potential harms associated with natural product legal high use”. 

Source: Arunotayanun W, Gibbons S. (2012). Natural product 'legal highs'.

Natural Product Reports, November 2012; 29(11): 1304-16.


Police definition of head shop
Police definition of ‘head shop’ 2013

A commercial retail outlet (including online businesses) specialising in the sale or supply of equipment, paraphernalia or literature related to the growing, production or consumption of cannabis, or other drugs, and includes the sale or supply of ‘New Age’ herbs, exotic plant materials or other ‘New Psychoactive Substances’ (aka ‘Legal or Herbal Highs’)

Their primary function is to promote, facilitate and glamorise the cultivation, production, preparation and consumption of drugs.

Source: ACPO Guidance on Policing New Psychoactive Substances Including Temporary Class Drugs (Nov. 2011)


Is your legal high really legal
Is your legal high really legal? 2013

Answer depends not only on which drug it is, but:

* when (the year)

* where (the country)

and

* who you are (eg. adult, doctor etc.)

Also: if not legal, how illegal is it? MoD Act 1971 UK -

class A, class B, class C or TCDO (supply only) – or Medicines Act 1968 etc..



7 major structural groups of synthetic cannabinoids
7 major structural groups of synthetic cannabinoids 2012

  • Naphthoylindoles

  • Naphthylmethylindoles

  • Naphthoylpyrroles

  • Naphthylmethylindenes

  • Phenylacetylindoles

  • Cyclohexylphenols

  • Benzoylindoles


The history of headshops
The history of headshops 2012

1990s mainly inert/mild herbal substances

(khat tincture banned as class C drug prepar.)

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2000- freshpsilocbyemushrooms/kits (banned 2005)

2006 partypills:‘ecstasy-like’drugs (some banned 2009)

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2007- mephedrone & cathinones get popular

2010 (13 & relatives banned in 2010); salvia div.

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2010- synthetic cannabinoids (eg. Black Mamba)

now laughing gas (nitrous oxide) – refill capsules etc

various new stimulants & hallucinogens

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Next: Deep Web (eg. Silk Road); electronic highs



The sun thursday 5 th may 2012
The Sun: Thursday 5 2012th May 2012

Legal Highs still for sale: Replacements for banned drugs

MARY JOY (£10 a gram): Similar to cannabis, users report

hallucinations and insomnia after taking it.

HE-MAN (£63 for 2 half-gram sachets): Reported to be the

new “Mexxy”, its named after the cartoon character as it

makes users feel like Masters Of The Universe. Side-effects

include loss of balance and hallucinations.

MPA (£15 a gram): Sold as bath salts and said to emulate

“Mexxy”. Causes palpitations and temperature spikes.

DOVES (£10 for 2 pills): Name linked to Love Doves, a type

of ecstasy. Users can overheat and suffer a racing heartbeat.

KARMA (£6 a gram): Leaves users dozy and confused.



Main reasons for drug use
Main reasons for drug use 2012

Initiation – Continuation – Cessation

Intoxication (high, buzz, pleasure)

Stimulation (energy, excitement; working, dancing, sex)

Relaxation (sedation, trance-state, reducing anxiety)

Psychonautics (exploring mind, tripping, hallucinations)

Socio-economic causes Drug Market

Family & childhood factors Availability

Income & social exclusion Price

Peer influence/friend-groups Quality/purity

Genes: personality, attitudes, etc.


My strange addiction us tv
My Strange Addiction (US TV) 2012

29 episodes about 50+ ‘addictions’ (2010 to 2012): done first for pleasure – typically a distortion of natural drives:

Snorting baby powder

Inhale fumes: moth-balls, petrol, cleaning fluids

Taste/swallow: toilet paper, cushion-foam, A-B wipes

Eat: cat-food/hair/plaster/tape/glass/soap/dirt/laxatives/ash

Drink: urine, nail polish, detergents, petrol, hand sanitizer

Skin habits: cutting, picking scabs, pulling hair out, nail-biting

Excess grooming: tanning/bleaching, make-up, plastic surgery

Excess exercising – body-building, cycling & risky sports

Excess computer/phone/technological habits – esp. gaming,

social networking, texting



Venn 2012

Diagram

Model of

Psycho-

Active

Drugs (by effects)



Drug harm ranking 2012
Drug-Harm Ranking 2012 2012

The ranking of combined self and social scores for harm:

Taylor M et al. (2012). Quantifying the RR of harm to self and others from substance

misuse: results from a survey of clinical experts across Scotland. BMJ Open 2012

http://bmjopen.bmj.com/content/2/4/e000774.long


Research has only started recently, but a review paper on the effects of synthetic cannabinoidsand wider implications is now available


Trends in deaths from stimulants e w
Trends in deaths from stimulants, E&W the effects of synthetic cannabinoidsand wider implications is now available

mephedrone * ecstasyamphetaminescocaine

2001 055 24 97

2002 056 38 128

2003 050 31 129

2004 04337 154

2005 05845 176

2006 048 44 190

2007 047 50 196

2008 04445 235

2009 027 49 202

2010 6 8 48 144

2011 61349 112

England & Wales figures come under heading of ‘mephedrone/cathinones’ .

2010: Scotland 4, N. Ireland 1 [UK: 11] 2011: Scotland 1, N.Ireland 2 [UK: 9]

3 other cathinone deaths in Scotland 2011: 4MEC, cathinone & MDPV (one each)

Thus UK had a total of 12 cathinone deaths in 2011.

Source: Office of National Statistics (England & Wales), 2012; etc.


7 uk responses to use of nps1
7. UK Responses to use of NPS the effects of synthetic cannabinoidsand wider implications is now available


Moda amendments from 2001 to 2010
MODA amendments, from 2001 to 2010 the effects of synthetic cannabinoidsand wider implications is now available

2001 35 phenethylamines [hallucinogens] A1

2003 GHB (gammahydroxybutyrate) C4

2005 psilocin-based mushrooms (live/fresh) A1

2005 ketamine C4

2009 GBL (gammabutyrolactone), 14BD (butanediol) C

(Dec.) BZP (benzylpiperazine) & other piperazinesC1

Synthetic cannabinoid receptor agonists * B1

2010 mephedrone & substituted cathinones B1

(April) [10+ stimulants + 2 entactogens]

2010 Naphyrone B1

(June)

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Red letter = MODA class (A-C) Red number = MODA schedule (1-5)


Banning of synthetic cannabinoids1
Banning of synthetic cannabinoids the effects of synthetic cannabinoidsand wider implications is now available

Under the 2009 Amendment Order to MoDA 1971, four types of synthetic cannabinoid were added to class B, schedule 1:

[2,3–Dihydro–5–methyl–3–(4–morpholinylmethyl)pyrrolo[1, 2, 3–de]–1,4–benzoxazin–6–yl]–1–naphthalenylmethanone.

3–Dimethylheptyl–11–hydroxyhexahydrocannabinol.

[9–Hydroxy–6–methyl–3–[5–phenylpentan–2–yl] oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl] acetate.

9-(Hydroxymethyl)–6, 6–dimethyl–3–(2–methyloctan–2–yl)–6a, 7, 10, 10a–tetrahydrobenzo[c]chromen–1–ol.

NABILONE was excluded by adding many statements such as:

“Any compound structurally derived from 3–(1–naphthoyl)indole or 1H–indol–3–yl–(1–naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent …” and so forth and so on…


Drugwatch
Drugwatch the effects of synthetic cannabinoidsand wider implications is now available

Lifeline originally developed RADAR: Rapid Assessment of Drug Activities & Risks, designed to provide information about drug use far more quickly than other systems (eg. NDTMS).

Applied for Lottery Funding, but were unsuccessful.

DrugWatch is currently an informal association of agencies including DrugScope, Lifeline and Release, who share an interest in establishing a robust early warning system in the UK for all types of drugs.

When appropriate, DrugWatch’s early warning system will communicate information to the drugs sector on new and emerging compounds, including controlled drugs & ‘legal highs’


Uk forensic early warning system
UK Forensic Early Warning System the effects of synthetic cannabinoidsand wider implications is now available

FEWS was set up to identity New Psychoactive Substances (NPS) more promptly to enable Government “to take action before a harmful substance takes a foothold in the UK”, and to feed into the UK-wide Drugs Early Warning System (DEWS).

Latest report is an annex to Drug Strategy Annual Review, May 2012. Aims are (1) to reduce the demand for NPS, (2) ensuring statutory services can provide effective treatment/recovery from NPS, (3) encouraging individuals to take personal responsibility, & (4) promoting the choice not to take unknown potentially harmful psychoactive drugs.

Analysis of 1,300 samples tested during January 2011 to March 2012 found 17 NPS (9 already banned in UK): 5 synthetic cannabinoids, 4 tryptamines, 2 phenethylamines, 1 cathinone & 5 other NPS.


CLUB DRUG USE IN ENGLAND: LITTLE IMPACT ON NUMBERS ENTERING TREATMENT

“Data collected since 2005-06 now tells us enough to form an idea of the scale and nature of the problems associated with the more established club drugs – ecstasy, ketamine, methamphetamine, GHB/GBL, and mephedrone. What is becoming clear is that despite the widespread use of club drugs, they are currently causing a treatment problem for relatively few people”.

National Treatment Agency (2012). “Club Drugs: Emerging Trends And Risks”. December 2012.


ad